Elevation Oncology

Elevation Oncology reports data from Phase I trial of EO-3021 for solid tumours
Clinical Trials Arena
Wed, 08/7/24 - 11:16 am
Elevation Oncology
EO-3021
solid tumors
clinical trials
The Next Wave of ADCs Could Treat Evasive Solid Tumors
BioSpace
Mon, 04/8/24 - 11:57 am
antibody-drug conjugate
AACR
solid tumors
Elevation Oncology
Tubulis
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Endpoints
Thu, 07/28/22 - 06:32 pm
Elevation Oncology
gastric cancer
pancreatic cancer
antibody-drug conjugate
With sickle cell disease study in sight, Graphite Bio draws up a $238M IPO
MedCity News
Sun, 06/27/21 - 10:47 pm
Graphite Bio
IPOs
sickle cell disease
Elevation Oncology
Monte Rosa
Elevation files for $100M IPO to fund tumor-agnostic candidate
Fierce Biotech
Mon, 06/7/21 - 11:11 am
Elevation Oncology
IPOs
Merrimack Pharmaceuticals
solid tumors
Elevation Oncology launches with $32.5 million Series A, gives new life to former Merrimack program
Endpoints
Tue, 07/21/20 - 10:58 am
Elevation Oncology
Merrimack
seribantumab
non-small cell lung cancer